Adefovir clinical trials
Includes 41 studies of Adefovir dipivoxil.
How each study uses adefovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 20 Sept 2002 · HEPSERA · NDA 021449 (FDA, Drugs@FDA; as adefovir dipivoxil)
- European Union
- 6 Mar 2003 · Hepsera · EMEA/H/C/000485 (EMA; as adefovir dipivoxil; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2006 (5)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 36 · Other 28
Gilead Sciences (17) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · GlaxoSmithKline (5) · Bukwang Pharmaceutical (3) · Bristol-Myers Squibb (3) · Hoffmann-La Roche (2) · Korea University (2) · Pharmasset (2)
Often tested with
Tested in the same studies.
Lamivudine (10) · Entecavir (8) · Telbivudine (6) · Tenofovir (5) · Clevudine (5) · Efavirenz (4) · Nelfinavir (2) · Abacavir (2)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses adefovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 64
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedPhase 4Thomas Jefferson UniversityNCT00307242Written as Adefovir Dipivoxil
- A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000892Written as Adefovir dipivoxil
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00033163Written as Adefovir dipivoxil
- Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00051077Written as Adefovir dipivoxil
- A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000912Written as Adefovir dipivoxil
- Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive LiverCompletedPhase 1/2Columbia UniversityNCT01146808Written as Adefovir dipivoxil and hepatitis B vaccination
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT00973219Written as Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
- Drug Transporter Interaction Study PHENTRA_2015_KPUKCompletedPhase 4University of CologneNCT02743260Written as Adefovir
- Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and FurosemideCompletedPhase 1Akebia TherapeuticsNCT03801759Written as Adefovir
- A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT01521975Written as Telbivudine, Adefovir dipivoxil
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis BCompletedPhase 4Hoffmann-La RocheNCT00922207Written as Adefovir
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedPhase 3Hoffmann-La RocheNCT00661076Written as adefovir dipivoxil
- Lamivudine and Adefovir to Treat Chronic Hepatitis BCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00023309Written as Lamivudine and adefovir
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownPhase 4Ruijin HospitalNCT02560649Written as Peginterferon alfa-2a plus Adefovir
- Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnPhase 4Bristol-Myers SquibbNCT00986778Written as Adefovir
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedPhase 3NovartisNCT00115245Written as Adefovir Dipivoxil
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnPhase 4Novartis PharmaceuticalsNCT00409019Written as Adefovir
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownPhase 4Asian-Pacific Alliance of Liver Disease, BeijingNCT02327689Written as Emtricitabine plus adefovir dipivoxil
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedPhase 4Bukwang PharmaceuticalNCT01263002Written as clevudine, Adefovir
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedPhase 4Bukwang PharmaceuticalNCT01264133Written as Clevudine, Adefovir
See all 64 studies that test adefovir →
Given beside what is tested · 7 — adefovir is usual care or a partner of the new treatment
- A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg PositiveCompletedPhase 4Hoffmann-La RocheNCT01086085Written as Adefovir
- EFFORT Further Extension StudyStatus unknownPhase 4Nanfang Hospital, Southern Medical UniversityNCT02826070Written as Adefovir dipivoxil
- Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BStatus unknownPhase 4Asan Medical CenterNCT02482272Written as Adefovir
- Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis BCompletedPhase 2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02366208Written as Adefovir
- Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis BStatus unknownPhase 3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02366247Written as Adefovir
- Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir AloneTerminatedPhase 3NovartisNCT00376259Written as adefovir dipivoxil
- Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B PatientsTerminatedPhase 4Inje UniversityNCT00798460Written as adefovir
As the comparator · 19 — what is tested is compared with adefovir
- Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)CompletedPhase 3GlaxoSmithKlineNCT01300234Written as Adefovir dipivoxil (ADV) tablets
- Lamivudine and Adefovir Dipivoxil Fixed Dose CombinationCompletedPhase 1GlaxoSmithKlineNCT01353742Written as Adefovir dipivoxil
- Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus AdefovirStatus unknownPhase 3Uijeongbu St. Mary HospitalNCT03236584Written as lamivudine plus adefovir combination
- PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)CompletedPhase 3Merck Sharp & Dohme LLCNCT00371761Written as Adefovir dipivoxil (adefovir)
- Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedPhase 3Novartis PharmaceuticalsNCT00640588Written as oral adefovir
- A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis BCompletedPhase 3Gilead SciencesNCT00116805Written as ADV
- A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis BCompletedPhase 3Gilead SciencesNCT00117676Written as ADV
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedPhase 4Keimyung University Dongsan Medical CenterNCT01732367Written as Lamivudine plus adefovir
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownPhase 4Taipei Veterans General Hospital, TaiwanNCT01491295Written as Lamivudine plus adefovir
- A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis BCompletedPhase 4Hoffmann-La RocheNCT02598063Written as Adefovir dipivoxil
- A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-BCompletedPhase 3Bukwang PharmaceuticalNCT00672867Written as Adefovir dipivoxil
- Efficacy Optimizing Research of Lamivudine TherapyCompletedPhase 4Nanfang Hospital, Southern Medical UniversityNCT01088009Written as lamivudine, adefovir
- Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic DecompensationCompletedPhase 3Bristol-Myers SquibbNCT00065507Written as Adefovir (ADV)
- An Study of Efficacy and Safety of ClevudineCompletedPhase 3Eisai Co., Ltd.NCT01192854Written as Adefovir
- Suboptimal Responders to Adefovir Switching to EntecavirCompletedPhase 4Bristol-Myers SquibbNCT00718887Written as Adefovir/Entecavir
- Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineCompletedPhase 1Genexine, Inc.NCT00513968Written as Adefovir
- Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnPhase 4NovartisNCT00606099Written as adefovir dipivoxil
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedPhase 4Bukwang PharmaceuticalNCT00641082Written as Adefovir dipivoxil
- A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis BStatus unknownPhase 2Huntington Medical Research InstitutesNCT00753467Written as Adefovir dipivoxil
Codes
What other systems call adefovir · ClinicalTrials.gg INT003330
- MeSH (NLM) C053001adefovirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6GQP90I798ADEFOVIRConfirmed FDA, NLM, Wikidata
- RxNorm 16521Confirmed FDA, Wikidata
- Wikidata Q353551adefovirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61526AdefovirOne source FDA
- DrugBank DB13868One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C053001 | adefovir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6GQP90I798 | ADEFOVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 16521 | — | Confirmed FDA, Wikidata |
| Wikidata | Q353551 | adefovir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61526 | Adefovir | One source FDA |
| DrugBank | DB13868 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.